Feingold syndrome
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Feingold syndrome | |
|---|---|
| File:Autosomal dominant - en.svg | |
| Synonyms | Oculodigitoesophagoduodenal syndrome |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Microcephaly, digital anomalies, esophageal atresia, duodenal atresia |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the MYCN gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | VACTERL association, CHARGE syndrome |
| Prevention | N/A |
| Treatment | Symptomatic treatment, surgical intervention |
| Medication | |
| Prognosis | Variable, depending on severity of symptoms |
| Frequency | Rare |
| Deaths | |
Feingold syndrome is a rare genetic disorder characterized by a combination of physical abnormalities and developmental delays. It is also known as Oculodigitoesophagoduodenal syndrome. The syndrome is named after Dr. Murray Feingold, who first described the condition.
Presentation[edit]
Individuals with Feingold syndrome typically present with a range of congenital anomalies. Common features include:
- Microcephaly (small head size)
- Brachydactyly (short fingers and toes)
- Clinodactyly (curved fingers)
- Esophageal atresia (a congenital condition where the esophagus does not develop properly)
- Duodenal atresia (a congenital condition where the duodenum is closed off rather than being a tube)
- Learning disabilities and developmental delays
Genetics[edit]
Feingold syndrome is primarily caused by mutations in the MYCN gene, which plays a crucial role in cell growth and development. The condition is inherited in an autosomal dominant manner, meaning that only one copy of the mutated gene is necessary for the disorder to be present.
Diagnosis[edit]
Diagnosis of Feingold syndrome is based on clinical evaluation, identification of characteristic physical features, and genetic testing to confirm mutations in the MYCN gene. Prenatal diagnosis may be possible through genetic testing if there is a known family history of the disorder.
Management[edit]
There is no cure for Feingold syndrome, and treatment is symptomatic and supportive. Management may involve:
- Surgical correction of esophageal atresia and duodenal atresia
- Physical therapy and occupational therapy to address developmental delays
- Special education services to support learning disabilities
Epidemiology[edit]
Feingold syndrome is a rare condition, and its exact prevalence is unknown. It affects both males and females equally.
